Bharat Biotech Has Submitted Data from Clinical Trials in the 2-18 Years Age Group for ... - Latest Tweet by ANI
The latest Tweet by ANI states, 'Bharat Biotech has submitted data from clinical trials in the 2-18 years age group for COVAXIN to CDSCO. The data has been thoroughly reviewed by the CDSCO and Subject Experts Committee and has provided their positive recommendations.'
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)